Vitrian invests in AmplifyBio’s biomanufacturing facility in Ohio
The $50m investment, with an option to scale up to $65m, will expand 350,000ft2 AMEC facility that houses AmplifyBio’s multi-modality process development and quality control labs and GMP manufacturing suites
Effects of interstate armed conflicts on the pharmaceutical industry
Unveiling the impact of misinformation and disinformation in the pharmaceutical industry
The ripple effects of inflation on the pharmaceutical industry
Extreme weather events: The implications for the pharmaceutical industry